Cargando…
Drug discovery in psychopharmacology: from 2D models to cerebral organoids
Psychiatric disorders are a heterogeneous group of mental illnesses associated with a high social and economic burden on patients and society. The complex symptomatology of these disorders, coupled with our limited understanding of the structural and functional abnormalities affecting the brains of...
Autores principales: | Rossetti, Andrea Carlo, Koch, Philipp, Ladewig, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787544/ https://www.ncbi.nlm.nih.gov/pubmed/31636494 http://dx.doi.org/10.31887/DCNS.2019.21.2/jladewig |
Ejemplares similares
-
Generation of Standardized and Reproducible Forebrain-type Cerebral Organoids from Human Induced Pluripotent Stem Cells
por: Krefft, Olivia, et al.
Publicado: (2018) -
Human cerebral organoids reveal progenitor pathology in EML1‐linked cortical malformation
por: Jabali, Ammar, et al.
Publicado: (2022) -
Anticholinergic Drugs in Geriatric Psychopharmacology
por: López-Álvarez, Jorge, et al.
Publicado: (2019) -
Psychopharmacology: From serendipitous discoveries to rationale design, but what next?
por: Robinson, Emma
Publicado: (2018) -
Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology
por: Tricklebank, Mark David, et al.
Publicado: (2021)